a.s.r. account plan
Sustainable insurance offerings
At a glance
a.s.r. is the second-largest insurer in the Netherlands, with 8,689 internal FTEs and FY2025 premiums and DC volume of €13,375m.
ASR Nederland N.V. (a.s.r.) is the second-largest insurer in the Netherlands, offering insurance, pensions and mortgages to private individuals, self-employed professionals and businesses, plus asset management for third parties. It operates only in the Netherlands, serves 5.2 million customers and distributes mainly through independent advisors, mandated brokers and intermediaries. In FY2025 premiums and DC volume rose 28.9% to €13,375m, the operating result reached €1,637m and the Solvency II ratio was 218%; it had 8,689 internal FTEs at end-2025. a.s.r. is listed on Euronext Amsterdam and included in the AEX Index.
Business units
Non-life
about 44% of FY2025 group volume (computed); premiums €5,846mP&C (top-three player with a 14.7% share), Disability (market leader with a 39.5% share) and Health insurance. FY2025 operating result was €474m with a combined ratio of 92.2%; Bovemij's insurance activities, about €400m of premium, joined on 1 July 2026. Robert van der Schaaf is COO Non-Life.
Life
about 57% of FY2025 group volume (computed); premiums and DC inflow €7,643mPensions (34% market share, 2.5 million participants), pension buy-outs, annuities, term life and funeral insurance. It is the largest contributor, with a FY2025 operating result of €1,259m; the life entities of a.s.r. and Aegon were legally merged on 2 July 2026. Willem van den Berg is COO Life.
Asset Management
Asset management, real estate funds and mortgages (about 7% market share), with third-party AuM of €37.3bn at end-2025. FY2025 operating result was €120m, rising 35.3% to €78m in H1 2026 on mortgage cost synergies.
Distribution and Services
Intermediaries, portfolio buyers, absence case management (Robidus), pension administration (TKP) and occupational health provider HumanTotalCare, fully owned since 1 October 2025. FY2025 fee income was €468m and operating result €66m.
Strategic priorities
- New strategy at the Capital Markets Day
- CEO Ingrid de Swart will present a new three-year strategy at the Capital Markets Day on 1 December 2026, as the 2024-2026 plan period ends.
- AI across all processes
- De Swart kept IT in her own portfolio and wants AI integrated in all of a.s.r.'s processes; AI spending through the holding runs at tens of millions, with Health used as the pilot ground.
- Consolidation of the Dutch market
- a.s.r. positions itself as an active and disciplined consolidator in Dutch P&C, and is interested in Life back books, Funeral portfolios and distribution companies; it has no appetite for acquisitions outside the Netherlands.
- Pensions under the Wtp
- a.s.r. aims to be the leading pension provider, targeting €8bn of pension DC inflow and €8bn of buy-outs, though part of the buy-out ambition may materialize beyond 2027.
- Value over volume in Non-life
- Targets are a P&C and Disability combined ratio of 92-94% with 3-5% growth; a.s.r. will accept slower Disability growth in 2027 to protect margins.
- 2026 financial targets
- Organic capital creation of €1,350m in 2026, Solvency II safely above 160% and operating return on equity above 12%.
Latest results
In H1 2026 the operating result rose 9.8% to €901m and net result attributable reached €809m (H1 2025: €126m), with an operating return on equity of 15.4%. Organic capital creation rose to €773m and the Solvency II ratio reached 222% after €455m of capital distributions. Non-life premiums grew 7.0% to €3,730m with a combined ratio of 91.6%, while Life volume fell because of one pension buy-out against three a year earlier. Management guides full-year 2026 organic capital creation north of the €1.35bn target.
Investments and deals
- Aegon Nederland integration
- The integration was completed with the legal merger of the life entities on 2 July 2026; run-rate cost synergies are targeted at €215m.
- Bovemij acquisition
- Bovemij's insurance activities were bought for €185m and closed on 1 July 2026, adding roughly €400m of annual premiums and access to the BOVAG ecosystem.
- HumanTotalCare
- The remaining 55% was bought on 1 October 2025 for €108m, adding over 2,000 professionals serving more than 65,000 employers.
- Pension buy-outs
- Three pension buy-outs totalling €2,810m were done in 2025, and one of €0.2bn in H1 2026.
- Technology and AI spending
- Operating expenses rose to €815m in H1 2026 because of HumanTotalCare and investment in new technology and AI.
Challenges and risks
- Rising disability claims
- Group disability incidence is elevated by psychological absenteeism and long COVID, worsened by the UWV backlog; the Disability combined ratio worsened to 94.2% in 2025.
- Competition in P&C and buy-outs
- Foreign capacity providers compete through mandated brokers in P&C, and a third competitor at Achmea is pressuring buy-out pricing.
- Cyber and third-party resilience
- Cyber and information security is a named risk, and the May 2026 NorthC data centre fire highlighted dependence on critical third parties.
- Regulation
- Wtp pension reform, DORA, the EU AI Act, CSRD and the Solvency II Review and IRRD from 30 January 2027 all require investment.
- Macroeconomic uncertainty
- The interim report cites the Middle East war, energy-driven inflation and the downgrade of Belgian government bonds.
What leadership says
“AI will become a permanent new colleague for everyone.”
“The completion of the Aegon integration and the CEO transition is a fantastic moment to reassess the strategy.”
“The minimum size for insurers to run their business in an economically viable way just continues to creep up every year.”
“We are no capital hoarders, so in case we can't find proper deployment, we will return it to shareholders.”
Where a supplier can help
- AI adoption and change management
- Tied to the AI priority: AI tooling for claims and customer contact, plus adoption and training support, fit a CEO who puts 70% of the transformation on people and adoption.
- Systems consolidation after acquisitions
- Tied to the Aegon integration and Bovemij acquisition: migration, platform and integration partners support the move to single IT landscapes.
- Occupational health and absence management
- Tied to the rising disability claims challenge: prevention, reintegration and mental-health services address the claims drivers a.s.r. names.
- Operational resilience and security
- Tied to the cyber and third-party resilience challenge and DORA: security, data-centre redundancy and vendor-risk providers address named risks.
- Pension administration for the Wtp
- Tied to the pensions priority: pension administration and conversion tooling support Wtp transitions and buy-outs.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like a.s.r.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report 2025 (ASR Nederland N.V.)
- a.s.r. (ASR Nederland N.V.) is the second-largest insurer in the Netherlands, listed on Euronext Amsterdam (AEX): insurance, pensions and mortgages for private individuals, self-employed professionals and businesses, plus asset management for third parties; 8,689 internal FTEs at end-2025 (2024: 7,373).
- FY2025: premiums and DC volume up 28.9% to €13,375m, operating result up €174m to €1,637m, operating return on equity 14.1%, organic capital creation (OCC) €1,315m (2024: €1,193m), Solvency II ratio 218% (2024: 198%), IFRS net result attributable €548m.
- Five segments: Non-life (P&C, Disability, Health; operating result €474m), Life (Pensions, Individual life & Funeral; €1,259m), Asset Management (asset management, real estate, mortgages; €120m), Distribution and Services (€66m) and Holding and Other (€-282m).
- Market positions: market leader in disability (39.5% share), top-three P&C insurer (14.7%), pensions market share 34% with 2.5 million participants, mortgages ~7%, top-three funeral insurer (19.2%).
- Aegon Nederland integration essentially completed in 2025: over two million policies migrated, ~300,000 mortgage accounts moved to Stater and ~550,000 life policies to LeanApps; legal merger of the life entities and decommissioning of Aegon systems planned for mid-2026; run-rate cost synergy target €215m in 2026.
- Capital: Partial Internal Model approved by DNB for ASR Levensverzekering (circa +12%-points on group Solvency II); S&P upgraded the insurance entities to A+ (IFSR); dividend €3.41 per share (+9.3%); €230m buybacks in 2025 and €175m announced for H1 2026.
- Growth moves: three pension buy-outs (€2,810m AuM), 100% of HumanTotalCare, De Onderlinge 1719 funeral book, Amvest split with PFZW, and in January 2026 agreement to buy Bovemij's insurance activities (~€400m premium).
- 2024-2026 targets: OCC €1,350m in 2026, Solvency II safely >160%, operating RoE >12%, P&C and Disability combined ratio 92-94% (2025: 92.2%) with 3-5% growth (2025: 3.0%), €8bn pension DC inflow and €8bn buy-outs.
- Risks named: (geo)political and economic uncertainty, climate change and biodiversity loss, cyber/information security, AI, Aegon NL integration, regulation (Wtp pension reform, Solvency II Review and IRRD from 30 January 2027); rising group disability claims from psychological absenteeism and long COVID.
- Leadership: CEO Jos Baeten's last report; Ingrid de Swart (COO/CTO) nominated as CEO at the 20 May 2026 AGM; she frames AI as moving 'from exploration to acceleration'.
- 2026 Interim Report (half-year results H1 2026)
- H1 2026 operating result up 9.8% to €901m, net result attributable €809m (H1 2025: €126m), operating return on equity 15.4%; organic capital creation (OCC) €773m (+€52m).
- Solvency II ratio 222% (end-2025: 218%) after €455m of capital distributions; holding liquidity €997m; financial leverage 21.0%.
- Non-life premiums +7.0% to €3,730m, organic P&C and Disability growth 6.0% (target 3-5%); combined ratio 91.6% (P&C 89.9%, Disability 93.3%, Health 99.6%).
- Life: one pension buy-out (€0.2bn) versus three (€2.8bn) a year earlier, so total premium and DC inflow fell 26.7% to €6,394m; Pension DC inflow +3.2% to €1,545m, annuities +38.0% to €436m, DC AuM €34.1bn.
- Fee-based: Asset Management operating result €78m (+35.3%) on mortgage cost synergies; Distribution and Services fee income €324m (+58.6%) with HumanTotalCare; mortgage origination down to €3.6bn under 'value over volume'; Knab mortgages (impact €10bn) moved to BAWAG.
- Aegon NL integration finished: life entities legally merged on 2 July 2026; Bovemij insurance activities (bought for €185m) closed on 1 July 2026, solvency impact around -3.5 points.
- Interim dividend €1.39 per share (+9.4%, €280m); €175m buyback completed in May 2026; on track for medium-term targets including €1,350m OCC in 2026.
- Operating expenses rose to €815m on HumanTotalCare and investment in new technology and AI; internal FTEs 8,650.
- Risks flagged: Middle East war and energy-driven inflation, the NorthC data centre fire (May 2026), cyber resilience, Belgian government bond downgrade.
- Ingrid de Swart (a.s.r.): 'This job is even more intense than I thought' (Management Scope)
- Ingrid de Swart has been CEO of a.s.r. since 20 May 2026, succeeding Jos Baeten; she has been on the executive board since 2019 and was COO before.
- She will present a new three-year strategy at the Capital Markets Day on 1 December 2026, calling the end of the Aegon integration and the CEO transition "a fantastic moment to reassess the strategy".
- She kept IT in her own portfolio as CEO to signal that technology and AI are "truly a top priority"; AI should be integrated "in all of a.s.r.'s processes" and become "a permanent new colleague for everyone".
- Her rule of thumb: IT/AI is about thirty percent of the transformation and seventy percent comes from colleagues and adoption; she took the top twenty-five executives to London to visit companies advanced in AI.
- New board split: CFO Ewout Hollegien stays, Willem van den Berg is COO Life and Robert van der Schaaf is the new COO Non-Life; the team was filled largely with internal candidates.
- Before taking over she spoke with about ten fellow CEOs, held a "reversed roadshow" with investors and analysts, and is on a summer tour of all employees.
- She wants a role in public debate on sustainable employability (a.s.r. is a major disability insurer), young people's burnout, financial self-sufficiency and the housing shortage.
- a.s.r. H1 2026 results conference call transcript
- Ingrid de Swart's first results call as CEO (19 August 2026), with CFO Ewout Hollegien: record OCC (€773m, up more than 7%) and record operating result (€901m), Solvency II ratio 222%.
- Aegon Nederland integration completed with the legal merger of the life entities on 2 July; Bovemij closed on 1 July, adds roughly €400m of annual premiums, should exceed the 12% return hurdle and contribute around €25m of run-rate OCC; integration expected to take about a year and a half.
- Positions a.s.r. as "an active and disciplined consolidator" in Dutch P&C, where the three largest hold around 65%; also interested in Life back books, Funeral portfolios and distribution companies, and still expects "one big insurer" to come to market; no appetite for acquisitions outside the Netherlands.
- Non-life growth 6% (Disability 8% after repricing, P&C 4%); combined ratio 91.6%; group disability risk rising with the UWV backlog, assumptions to be reassessed at year-end; willing to grow below 3% in Disability in 2027 to protect margins.
- Pensions: DC inflow €1.5bn, DC AuM €34bn, annuities +38%; buy-out market more competitive (Achmea entering), €20-30bn opportunity, €8bn ambition may extend beyond 2027, 12% hurdle kept.
- AI investment running at "tens of millions" through the holding; health used as the AI "nursery"; full AI story promised for the 1 December 2026 Capital Markets Day.
- Guidance: full-year 2026 OCC north of the €1.35bn target; Bovemij plus removal of the deterministic adjustment about -7 to -8 solvency points; Solvency II review expected to add around 10 points in H1 2027; exploring longevity reinsurance.
- a.s.r. full-year 2025 results conference call transcript
- Jos Baeten's last results call as CEO (18 February 2026): integration of Aegon NL completed within three years of closing; OCC up over 10% to €1,315m, operating result up 12% to €1,637m, Solvency II 218% including a 12-point uplift from the partial internal model for ASR Life.
- Capital returns: dividend €3.41 per share (+9.3%, 12% compound annual growth since the 2016 IPO), €175m buyback announced, about 75% of 2025 OCC returned and 25% invested in inorganic growth; the €225m 2026 buyback tranche can be accelerated if Aegon sells down further. "We are no capital hoarders"
- Disability: about €50m of provisions in each half of 2025 plus significant price increases from 1 January 2026 to address psychological absenteeism, long COVID and the UWV backlog.
- P&C: competition from foreign players via mandated brokers in capital-light products; a.s.r. sticks to value over volume and plans motor premium rises of 5-7%, in some cases towards 10%.
- Buy-outs: three deals of almost €3bn in 2025; a third competitor (Sixth Street at Achmea) is pressuring prices; €8bn target kept but may take a year longer; 12% IRR minimum.
- M&A: Bovemij as proof point; a tail of 15-20 P&C players holding roughly 35% of the market; Funeral and Life still to consolidate.
- CFO Hollegien: Solvency II review now expected from January 2027 (about +10 points gross); exploring longevity reinsurance on about €10bn of back-book liabilities; AI and technology investment detail deferred to the 1 December 2026 Capital Markets Day.
Questions about a.s.r.
What does a.s.r. do?
a.s.r. is a Dutch insurer offering non-life, disability, health, pensions, life and funeral insurance and mortgages, plus asset management, to individuals, self-employed professionals and businesses in the Netherlands.
How big is a.s.r.?
FY2025 premiums and DC volume were €13,375m with an operating result of €1,637m. In H1 2026 the operating result was €901m.
How many employees does a.s.r. have?
8,689 internal FTEs at end-2025 and 8,650 at mid-2026.
Who leads a.s.r.?
Ingrid de Swart has been CEO since 20 May 2026, succeeding Jos Baeten; Ewout Hollegien is CFO.
What is a.s.r.'s strategy?
Profitable growth under value over volume, consolidation of the Dutch market, leadership in pensions and the integration of AI across processes; a new three-year strategy is due on 1 December 2026.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)